2005-05-23 H.R. 2520: Stem Cell Therapeutic and Research Act of 2005 2005-05-23 H.R. 2520: Stem Cell Therapeutic and Research Act of 2005 Public contracts Authorization Health education Medical care Data banks Federal advisory bodies Government paperwork Budgets Executive departments Government contractors Government information Department of Health and Human Services Emergency management Hazardous substances Health policy Law Science policy Technology Medical research Communication in medicine Medicine Communications Telecommunication Criminal justice Armed forces Defense policy Directories Communication in science Donation of organs, tissues, etc. Genetic research Informed consent (Medical law) Transplantation of organs, tissues, etc. Electronic data interchange Government publicity Medical records Weapons systems Terrorism Tissue banks Ionizing radiation Emergency medicine Chemical warfare Blood banks Cytology Genetics Health information systems enacted H.R. 2520: To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program. Referred to the House Committee on Energy and Commerce. 2005-05-23 Referred to the Subcommittee on Health. 2005-05-24 Mr. Barton (TX) moved to suspend the rules and pass the bill. 2005-05-24T12:19:00-04:00 Considered under suspension of the rules. 2005-05-24T12:19:00-04:00 DEBATE - The House proceeded with forty minutes of debate on H.R. 2520. 2005-05-24T12:19:00-04:00 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. 2005-05-24T13:36:00-04:00 Considered as unfinished business. 2005-05-24T18:06:00-04:00 pass On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 431 - 1 (Roll no. 205). 2005-05-24T18:15:00-04:00 Received in the Senate. 2005-05-26 Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 256. 2005-10-24 Measure laid before Senate by unanimous consent. 2005-12-16 pass Passed Senate with an amendment by Unanimous Consent. 2005-12-16 Message on Senate action sent to the House. 2005-12-16 Mr. Deal (GA) moved that the House suspend the rules and agree to the Senate amendment. 2005-12-17T15:50:00-05:00 DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and agree to the Senate amendment to H.R. 2520. 2005-12-17T15:50:00-05:00 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 5, rule I, the chair announced that further proceedings on the motion would be postponed. 2005-12-17T16:34:00-05:00 On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 413 - 0 (Roll no. 664). 2005-12-17T19:34:00-05:00 Cleared for White House. 2005-12-17 Presented to President. 2005-12-19 Signed by President. 2005-12-20 Became Public Law No: 109-129. 2005-12-20 S. 1317: Stem Cell Therapeutic and Research Act of 2005 (109th Congress) S. 1317: Stem Cell Therapeutic and Research Act of 2005 109 H.R. 2520: Stem Cell Therapeutic and Research Act of 2005 (109th Congress) 2520 h Stem Cell Therapeutic and Research Act of 2005 To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program. HouseBill VoteAction LegislativeAction OfficialTitle ShortTitle